![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | August 20, 2008 | ||||
Last Updated Date | August 20, 2008 | ||||
Start Date † | August 2007 | ||||
Current Primary Outcome Measures † |
Pain and Anxiety [ Time Frame: up to 3 times a day ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures † | |||||
Original Secondary Outcome Measures † | |||||
Descriptive Information | |||||
Brief Title † | Pain Control After Trauma | ||||
Official Title † | Pain Control After Trauma | ||||
Brief Summary | Using Virtual Reality as a form of pain control for trauma patients. |
||||
Detailed Description | The purpose of the study is to investigate the effectiveness of virtual reality (a form of distraction) in order to reduce patients' pain from trauma. |
||||
Study Phase | |||||
Study Type † | Interventional | ||||
Study Design † | Treatment, Randomized, Single Blind (Caregiver), Parallel Assignment | ||||
Condition † | Trauma | ||||
Intervention † | Behavioral: Virtual Reality | ||||
Study Arms / Comparison Groups |
|
||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Recruiting | ||||
Enrollment † | 200 | ||||
Estimated Completion Date | June 2012 | ||||
Estimated Primary Completion Date | June 2012 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 12 Years and older | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† | |||||
Location Countries † | United States | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00739076 | ||||
Responsible Party | David R. Patterson, PhD., University of Washington | ||||
Secondary IDs †† | R01GM42725-09A1 | ||||
Study Sponsor † | National Institutes of Health (NIH) | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | National Institute of General Medical Sciences (NIGMS) | ||||
Verification Date | August 2008 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |